Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis

In brief

This is a Phase 1b/2a study with the primary objective to determine if BX004-A is safe and tolerable. Exploratory objectives include whether BX004-A reduces sputum Pseudomonas aeruginosa (PsA) bacterial load in CF subjects with chronic PsA pulmonary infection.

Key facts

Study ID
NCT05010577
Run by
BiomX, Inc.
People needed
43
Starts
2022-06-21
Expected to finish
2024-03-10
Last updated by the study team
2025-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.